Sangamo Therapeutics
SGMO
SGMO
210 hedge funds and large institutions have $767M invested in Sangamo Therapeutics in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 205 → 210 (+5)
20% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 69
Holders
210
Holding in Top 10
1
Calls
$14.1M
Puts
$11M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$9.38M | |
| 3 | +$6.26M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.32M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.07M |
Top Sellers
| 1 | -$4.29M | |
| 2 | -$3.54M | |
| 3 | -$3.27M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.26M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$3.23M |